Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 5 analysts offering 12 month price targets for Innate Pharma SA have a median target of 5.70, with a high estimate of 8.40 and a low estimate of 2.30. The median estimate represents a 178.05% increase from the last price of 2.05.
High | 309.8% | 8.40 |
Med | 178.0% | 5.70 |
Low | 12.2% | 2.30 |
Earnings history & estimates in EUR
Average growth rate | -6.54% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +14.38% |
More ▼